Evidence map›Paper›PMID 41120314›Full record

ArticleNature communications2025

CENP-E initiates chromosome congression by opposing Aurora kinases to promote end-on attachments.

Kruno Vukušić, Iva M Tolić

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kruno VukušićDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia. kvukusic@irb.hr.ORCID http://orcid.org/0000-0002-4867-6080
Iva M TolićDivision of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia. tolic@irb.hr.ORCID http://orcid.org/0000-0003-1305-7922

Funding

EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj) Grant KK.01.1.1.04.0057Hrvatska Zaklada za Znanost (Croatian Science Foundation) IPCH-2022-10-9344
6 · The paper itself

Abstract

Accurate cell division relies on rapid chromosome congression. The kinetochore motor protein CENP-E/kinesin-7 is uniquely required for congression of polar chromosomes. It is currently assumed that CENP-E drives congression by gliding kinetochores along microtubules independently of their biorientation. Here, by studying chromosome movement under different levels of CENP-E activity, we favor an alternative model in which CENP-E initiates congression by promoting stabilization of end-on attachments. In this way, CENP-E accelerates congression initiation without significantly contributing to subsequent movement. Stabilization of end-on attachments on polar chromosomes without CENP-E is delayed due to Aurora kinase-mediated hyperphosphorylation of microtubule-binding proteins and expansion of the fibrous corona. CENP-E counters this by reducing Aurora B-mediated phosphorylation in a BubR1-dependent manner, thereby stabilizing initial end-on attachments, facilitating removal of the fibrous corona, and triggering biorientation-dependent chromosome movement. These findings support a unified model of chromosome movement in which congression is intrinsically coupled to biorientation.

Indexed as

Aurora Kinase BAurora KinasesChromosomal Proteins, Non-HistoneChromosome SegregationKinetochoresHeLa CellsHumansMicrotubulesPhosphorylationProtein Serine-Threonine KinasesAURKB protein, humanAurora Kinase BAurora KinasesBUB1 protein, humancentromere protein EChromosomal Proteins, Non-HistoneProtein Serine-Threonine Kinases

Identifiers

PMID41120314
PMCPMC12540835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.